Form 4: Director Elizabeth Geary Receives Medifast Stock Grant

Medifast, Inc. director Elizabeth A. Geary was granted 11,680 restricted stock units as part of the company's director compensation plan.

Summary

• Director Elizabeth A. Geary acquired 11,680 restricted stock units (RSUs) on May 26, 2026.
• The grant was issued under the Medifast, Inc. Director's Deferred Compensation Plan as payment for annual director fees.
• Each RSU represents the right to receive one share of Medifast common stock.
• Following this transaction, the reporting person's total beneficial ownership is 31,225 shares.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine regulatory disclosure regarding director compensation, which carries a neutral sentiment.

Positives

• The transaction reflects alignment between director compensation and long-term shareholder value through equity-based incentives.

Negatives

• None identified.

Risks

• The value of the granted equity is subject to market volatility and the future performance of Medifast, Inc. common stock.

Future Outlook

The granted restricted stock units are scheduled to vest in full on May 26, 2027.

Industry Context

StockSavvy.ai notes that equity-based compensation for board members is a standard corporate governance practice designed to ensure directors maintain a vested interest in the company's long-term performance.

Comparison to Industry Standards

• The use of restricted stock units for director compensation is consistent with standard practices among publicly traded companies in the consumer goods and health sectors.

Corporate Governance

Stakeholder Impact

• Shareholders: Minimal impact; reflects standard director compensation practices.

Next Steps

• Vesting of the 11,680 restricted stock units on May 26, 2027.

Key Dates

Keywords

Medifast, MED, Form 4, Insider Trading, Director Compensation, Restricted Stock Units